- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05752292
Study to Understand Risk Information to Support and Empower (SUNRISE)
November 13, 2023 updated by: University of California, Davis
Optimizing a Scalable Intervention to Maximize Guideline-recommended Diabetes Testing After GDM
The aim of this trial is to test components of a digital health outreach intervention to promote uptake of postpartum screening and lifestyle programs for diabetes prevention among patients with gestational diabetes (GDM).
The outreach intervention, designed to be interactive and delivered online, includes standard health information plus up to four theory-based components, targeting motivational and logistical barriers to engaging in diabetes preventive care during the postpartum period.
The trial leverages the Multiphase Optimization Strategy (MOST) using a randomized factorial study design.
Study Overview
Status
Enrolling by invitation
Conditions
Study Type
Interventional
Enrollment (Estimated)
2000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Oakland, California, United States, 94612
- Kaiser Permanente Northern California
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Current pregnancy complicated by gestational diabetes mellitus (GDM)
- Age: 18 years and older
- Contact with the Kaiser Permanente Northern California (KPNC) Regional Perinatal Service Center
- Able to communicate in English
Exclusion Criteria:
- Diagnosis of diabetes before pregnancy
- Maternal or infant current hospitalization
- Pregnancy loss
- History of eating disorder
- Previously requested not to receive research invitations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Condition 1
Standard health message + VA + TRI + MI+ AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
|
Experimental: Condition 2
Standard health message + VA + TRI + MI
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
|
Experimental: Condition 3
Standard health message + VA + TRI + AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts to problem solve challenges
|
Experimental: Condition 4
Standard health message + VA + TRI
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
|
Experimental: Condition 5
Standard health message + VA + MI+ AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
|
Experimental: Condition 6
Standard health message + VA + MI
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts based on principles of motivational interviewing
|
Experimental: Condition 7
Standard health message + VA + AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
Interactive prompts to problem solve challenges
|
Experimental: Condition 8
Standard health message + VA
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to reflect on core personal values
|
Experimental: Condition 9
Standard health message + TRI + MI+ AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
|
Experimental: Condition 10
Standard health message + TRI + MI
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts based on principles of motivational interviewing
|
Experimental: Condition 11
Standard health message + TRI + AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
Interactive prompts to problem solve challenges
|
Experimental: Condition 12
Standard health message + TRI
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to provide tailored information on risk factors for type 2 diabetes
|
Experimental: Condition 13
Standard health message + MI+ AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts based on principles of motivational interviewing
Interactive prompts to problem solve challenges
|
Experimental: Condition 14
Standard health message + MI
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts based on principles of motivational interviewing
|
Experimental: Condition 15
Standard health message + AP
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
Interactive prompts to problem solve challenges
|
Experimental: Condition 16
Standard health message
|
Standard health information about postpartum screening and lifestyle programs for diabetes prevention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Completion of recommended postpartum diabetes screening.
Time Frame: 4-12 weeks postpartum
|
Completion of a 75-gram, 2-hour oral glucose tolerance test (OGTT)
|
4-12 weeks postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Completion of any recommended postpartum diabetes screening test.
Time Frame: 4-52 weeks postpartum
|
Completion of any screening test (OGTT, fasting plasma glucose, or HbA1c)
|
4-52 weeks postpartum
|
Uptake of a lifestyle program for diabetes prevention.
Time Frame: 4-52 weeks postpartum
|
Enrollment in a lifestyle program for diabetes prevention among women without type 2 diabetes mellitus according to any screening result
|
4-52 weeks postpartum
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Susan D Brown, PhD, University of California, Davis
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 13, 2023
Primary Completion (Estimated)
September 1, 2025
Study Completion (Estimated)
February 1, 2026
Study Registration Dates
First Submitted
February 16, 2023
First Submitted That Met QC Criteria
February 28, 2023
First Posted (Actual)
March 2, 2023
Study Record Updates
Last Update Posted (Actual)
November 15, 2023
Last Update Submitted That Met QC Criteria
November 13, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1826240
- R01DK122087 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus, Type 2
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States
-
RWTH Aachen UniversityBoehringer IngelheimCompletedDiabetes Mellitus Type 2 (T2DM)Germany
-
University Hospital Inselspital, BerneCompletedType 2 Diabetes MellitusSwitzerland
-
India Diabetes Research Foundation & Dr. A. Ramachandran...CompletedTYpe 2 Diabetes MellitusIndia
-
Scripps Whittier Diabetes InstituteSan Diego State UniversityCompletedType 2 Diabetes Mellitus (T2DM)United States
-
US Department of Veterans AffairsAmerican Diabetes AssociationCompletedType 2 Diabetes MellitusUnited States
-
Dexa Medica GroupCompletedType-2 Diabetes MellitusIndonesia
-
Griffin HospitalCalifornia Walnut CommissionCompletedDIABETES MELLITUS TYPE 2United States
-
Diabetes Foundation, IndiaNational Diabetes Obesity and Cholesterol FoundationRecruitingType 2 Diabetes Mellitus With ComplicationIndia
Clinical Trials on Standard Health Information
-
Duke UniversityDuke Cancer InstituteCompleted
-
University Hospital of SplitCroatian Science FoundationCompletedUnderstanding Cochrane Systematic ReviewsCroatia
-
VA Office of Research and DevelopmentRegenstrief Institute, Inc.CompletedCardiovascular Diseases | Heart Failure | Diabetes Mellitus | Asthma | OsteoporosisUnited States
-
Taipei Medical University WanFang HospitalNo longer availableValuable Suggestions to Improve Health Care Quality Transparent and Accessible Medical Care
-
University of PennsylvaniaCompletedBehavioral Variant of Frontotemporal Dementia | Caregiver Stress SyndromeUnited States
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)TerminatedHypertension | Diabetes Mellitus | Diabetes
-
Meir Medical CenterCompletedChildhood ObesityIsrael
-
University of PittsburghCompleted
-
University of Missouri-ColumbiaNational Library of Medicine (NLM)CompletedDepression | HIV Infections | Hypertension | Obesity | Diabetes Mellitus | Back Pain | Urinary Incontinence | Irritable Bowel Syndrome | Insomnia | Asthma | Anxiety | Sinusitis | Shoulder Pain | Allergic Rhinitis | Urinary Tract Infection | Vaginitis | Bursitis | Hyperlipidemia | Esophageal Reflux | Benign Prostatic Hypertrophy | Osteoporosis... and other conditionsUnited States
-
University of Missouri-ColumbiaNational Library of Medicine (NLM)CompletedDepression | Coronary Artery Disease | HIV Infections | Smoking Cessation | Hypertension | Obesity | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Hypothyroidism | Back Pain | Urinary Incontinence | Irritable Bowel Syndrome | Diarrhea | Migraine Disorders | Cough | Sleep Initiation and Maintenance... and other conditions